NASHVILLE, Tenn. / Nov 13, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it collected 19,846 pounds, approximately 13.6 million doses, of unused or expired medications during its seventh annual “Crush the Crisis” national prescription drug take back day. In total, the organization has now collected more than 108,500 pounds of medication since launching “Crush the Crisis” as an enterprise initiative in 2019.
“I am incredibly proud of our organization in this milestone year,” said Dr. Randy Fagin, senior vice president and chief quality officer at HCA Healthcare. “At our core, we are people taking care of people, and our annual Crush the Crisis take back day is a powerful reflection of that commitment. I am grateful to all of our colleagues and local law enforcement partners for helping us to create healthier tomorrows for our communities.”
HCA Healthcare facilities across all 15 of the Company’s U.S. divisions partnered with local law enforcement to help community members safely and anonymously dispose of unused or expired medication. The events were held in alignment with the Drug Enforcement Administration’s (DEA) National Prescription Drug Take Back Day, which collected 571,054 pounds of medication.
HCA Healthcare facilities that helped collect the largest amount of medication during this year’s event include:
Drawing on data from its approximately 44 million annual patient encounters, HCA Healthcare uses the science of “big data” to help reduce prescription drug misuse and transform pain management, with initiatives in surgical, emergency and other care settings, including:
HCA Healthcare also proudly collaborates with and provides clinical insight to the National Academy of Medicine’s (NAM) Action Collaborative on Combatting Substance Use and Opioid Crises.
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 191 hospitals and approximately 2,500 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its approximately 44 million annual patient encounters to advance science, improve patient care and save lives.
All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to HCA Healthcare, Inc. and its affiliates.
| Last Trade: | US$481.06 |
| Daily Change: | 2.92 0.61 |
| Daily Volume: | 1,190,315 |
| Market Cap: | US$109.770B |
October 31, 2025 October 27, 2025 October 24, 2025 August 27, 2025 | |

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load